Globus Medical Inc (GMED)
NYSE: GMED · Surgical & Medical Instruments & Apparatus · Audubon, PA · filing with the SEC since 2003
Grade7.0
◀ Past 6.6● Present 7.7▶ Future 6.4
Who owns Globus Medical Inc
As filed with the SECHolders of 5% or more
3
Blackrock, Inc. holds 8% of Class A Stock, as its SCHEDULE 13G/A filed Oct 27, 2026 says.
Directors and officers
13
report now, of 21 people on the record since 2012. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Oct 27, 2026 · Class A Stock · 9.1% in Apr 24, 2025
Janus Henderson Group PLC
SCHEDULE 13G/A · filed May 14, 2025 · Class A Common Stock · 5.8% in Feb 14, 2025
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
What GMED reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Nuvasive
A company bought · acquisition · Aug 2023 · owns, named in the 10-K filed Feb 24, 2026
Fibriant B.v.
A company bought · asset acquisition · owns, named in the 10-K filed Feb 24, 2026
Nevro Merger Agreement
A company bought · acquisition · owns, named in the 10-K filed Feb 24, 2026
NuVasive Merger Agreement
A company bought · acquisition · owns, named in the 10-K filed Feb 24, 2026
21 subsidiaries in 10 countries, from the list filed with the 10-K filed Feb 24, 2026.
Insider tradesForm 4
13sales
0purchases
8sales on a scheduled plan
7people selling
$16.0Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window7 of 21 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Tobin James R | director | 3 | $5.4M | 0 | 0 | $0 |
| Davidar David D | Senior VP, Operations | 2 | $4.2M | 0 | 0 | $0 |
| Huller Kelly | EVP, GC, Corporate Secretary | 3 | $3.4M | 3 | 0 | $0 |
| Zarrilli Stephen T | director | 1 | $2.2M | 0 | 0 | $0 |
| Kline Kyle | Senior Vice President, CFO | 2 | $2.0M | 2 | 0 | $0 |
| Norwalk Leslie V | director | 2 | $600,000 | 2 | 0 | $0 |
| Rhoads Ann D | director | 1 | $400,000 | 1 | 0 | $0 |